Ginkgo Bioworks Holdings (DNA) Net Margin (2020 - 2026)
Ginkgo Bioworks Holdings posted quarterly Net Margin of 33.52% for Q1 2026, down 1352.0% year-on-year from 2.68% in Q1 2025, and up 86.14% on a QoQ basis from 241.8% in Q4 2025.
Ginkgo Bioworks Holdings (DNA) has 7 years of Net Margin data on file, last reported at 33.52% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 1352.0% year-over-year to 33.52%; the trailing twelve-month figure through Mar 2026 stood at 161.58% (up 943.0% YoY), and the FY2025 full-year result was 183.81%, up 5713.0% from the prior year.
- Net Margin for Q1 2026 stood at 33.52%, up from 241.8% in the prior quarter.
- Across five years, Net Margin topped out at 20.0% in Q1 2025 and bottomed at 1009.26% in Q3 2022.
- The 5-year median for Net Margin is 245.25% (2024), against an average of 316.55%.
- Peak annual rise in Net Margin reached 90475 bps in 2022, while the deepest fall reached 87732 bps in 2022.
- A 5-year view of Net Margin shows it stood at 176.1% in 2022, then sank by 246 bps to 609.1% in 2023, then surged by 60 bps to 245.25% in 2024, then gained by 1 bps to 241.8% in 2025, then jumped by 86 bps to 33.52% in 2026.
- The last three Net Margin figures came in at 33.52% (Q1 2026), 241.8% (Q4 2025), and 207.93% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.65% |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | -33.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.52% |
| Dec 31, 2025 | -241.80% |
| Sep 30, 2025 | -207.93% |
| Jun 30, 2025 | -121.56% |
| Mar 31, 2025 | -20.00% |
| Dec 31, 2024 | -245.25% |
| Sep 30, 2024 | -63.34% |
| Jun 30, 2024 | -386.40% |
| Mar 31, 2024 | -437.25% |
| Dec 31, 2023 | -609.10% |
| Sep 30, 2023 | -546.44% |
| Jun 30, 2023 | -215.12% |
| Mar 31, 2023 | -253.98% |
| Dec 31, 2022 | -176.10% |
| Sep 30, 2022 | -1,009.26% |
| Jun 30, 2022 | -463.68% |
| Mar 31, 2022 | -350.65% |
| Dec 31, 2021 | -1,080.85% |
| Sep 30, 2021 | -131.95% |
| Jun 30, 2021 | -124.81% |
| Mar 31, 2021 | -169.58% |
| Dec 31, 2020 | -144.73% |
| Sep 30, 2020 | -196.41% |